These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9846844)

  • 1. Thermogenic effects of sibutramine in humans.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Am J Clin Nutr; 1998 Dec; 68(6):1180-6. PubMed ID: 9846844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.
    Hansen DL; Toubro S; Stock MJ; Macdonald IA; Astrup A
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1016-24. PubMed ID: 10557021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
    Walsh KM; Leen E; Lean ME
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women.
    Halford JC; Boyland EJ; Cooper SJ; Dovey TM; Huda MS; Dourish CT; Dawson GR; Wilding JP
    J Psychopharmacol; 2010 Jan; 24(1):99-109. PubMed ID: 18755818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.
    Hanotin C; Thomas F; Jones SP; Leutenegger E; Drouin P
    Int J Obes Relat Metab Disord; 1998 Jan; 22(1):32-8. PubMed ID: 9481597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sibutramine on energy expenditure in African American women.
    Starling RD; Liu X; Sullivan DH
    Obes Res; 2001 Apr; 9(4):251-6. PubMed ID: 11331428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sibutramine on energy expenditure and body composition in obese adolescents.
    Van Mil EG; Westerterp KR; Kester AD; Delemarre-van de Waal HA; Gerver WJ; Saris WH
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1409-14. PubMed ID: 17264187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A; Inbar O; Vaisman N
    Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sibutramine on resting metabolic rate and weight loss in overweight women.
    Seagle HM; Bessesen DH; Hill JO
    Obes Res; 1998 Mar; 6(2):115-21. PubMed ID: 9545017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modalities of the food intake-reducing effect of sibutramine in humans.
    Chapelot D; Marmonier C; Thomas F; Hanotin C
    Physiol Behav; 2000 Jan; 68(3):299-308. PubMed ID: 10716539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry.
    Saraç F; Pehlivan M; Celebi G; Saygili F; Yilmaz C; Kabalak T
    Adv Ther; 2006; 23(6):1016-29. PubMed ID: 17276969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sibutramine, an upcoming drug for weight loss acting on energy consumption and energy expenditure].
    Astrup A
    Acta Med Austriaca; 1998; 25(4-5):146-9. PubMed ID: 9879391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
    Birkenfeld AL; Schroeder C; Pischon T; Tank J; Luft FC; Sharma AM; Jordan J
    Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the sibutramine effect on satiety with a visual analogue scale in obese adolescents].
    Corrêa LL; Platt MW; Carraro L; Moreira RO; Faria Júnior R; Godoy-Matos AF; Meirelles RM; Póvoa LC; Appolinário JC; Coutinho WF
    Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):286-90. PubMed ID: 16184258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-obesity drugs: what does sibutramine offer? An analysis of its potential contribution to obesity treatment.
    Van Gaal LF; Wauters MA; De Leeuw IH
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():35-40. PubMed ID: 9792480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.